ClinicalTrials.Veeva

Menu

Impact of Long COVID-19 on the Health and Quality of Life of Military Personnel (Active or Retired) and Their Families (IMP@LA)

D

Direction Centrale du Service de Santé des Armées

Status

Enrolling

Conditions

COVID-19

Treatments

Other: Semi-structured interview
Other: Online questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05200832
2021PPRC06
2021-A02623-38 (Other Identifier)

Details and patient eligibility

About

Severe and sometimes irreversible sequelae are observed in people who have developed a severe form of COVID-19 (pulmonary, cardiovascular, renal, neurological sequelae among others). More than 10% of individuals who contracted the disease, even in a mild form, still have at least one of the initial symptoms at six months, also known as prolonged symptoms or long COVID syndrome. The most frequently observed symptoms are asthenia, neurological disorders (headache, anosmia, ageusia, etc.), cardio-thoracic disorders, pain, digestive or skin disorders. Very recently, the first results of a British prospective cohort study (PHOSPCovid) indicate that more than half of the COVID-19 survivors who were hospitalised experienced a very severe to moderate deterioration in their mental and/or physical health five months after hospitalisation. Women are particularly affected. Another American study shows that 85% of non-hospitalised COVID-19 patients developed at least 4 neurological symptoms impacting their quality of life. The most common are: "brain fog" (81%), headaches (68%), numbness or tingling (60%), taste impairment (59%) and loss of smell (55%).

These disabling symptoms may persist for weeks or months, deteriorating the quality of life of patients and making it difficult for some to return to a normal life. On the basis of current knowledge concerning the long-term sequelae of SARS-CoV-2 infection, it seems necessary to offer these subjects a specific care pathway and to adapt their living and working conditions beyond their medical care.

The present study is aimed at measuring the impact of long COVID on the health and quality of life of the defence community (military personnel and their families).

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years-old
  • Be affiliated to the French military health insurance

Exclusion criteria

  • Age < 18 years-old

Trial design

10,000 participants in 2 patient groups

COVID+
Description:
Participants who have experienced COVID-19
Treatment:
Other: Semi-structured interview
Other: Online questionnaire
COVID-
Description:
Participants who have not experienced COVID-19
Treatment:
Other: Semi-structured interview
Other: Online questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Aurélie MAYET, MD; Chrystel LAVAGNA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems